Ipratropium class?

What is Ipratropium and its classification?

Ipratropium is an anticholinergic medication, classified as a muscarinic receptor antagonist. It is primarily used to treat respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and chronic bronchitis [1].

How does Ipratropium work?

Ipratropium works by relaxing the muscles in the airways, making it easier to breathe. It does this by blocking the action of acetylcholine, a neurotransmitter that causes the muscles to contract. By blocking acetylcholine, ipratropium helps to open up the airways, allowing air to flow in and out more easily [1].

What are the common forms of Ipratropium?

Ipratropium is available in several forms, including:

* Inhalation solution: a liquid solution that is administered through a nebulizer or inhaler
* Inhalation powder: a dry powder that is inhaled through a special device
* Nebulizer solution: a liquid solution that is used with a nebulizer to create a mist that is inhaled

Who makes Ipratropium?

Ipratropium is manufactured by several pharmaceutical companies, including Boehringer Ingelheim, which has a patent for the medication that expires in 2025 (DrugPatentWatch.com) [2].

Is Ipratropium available as a generic?

Yes, ipratropium is available as a generic medication. Several companies have developed generic versions of the medication, including Teva, Sandoz, and Fresenius Kabi.

Sources:

[1] National Institute of Health (NIH). (2022). Ipratropium. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK526006/

[2] DrugPatentWatch.com. (2022). Ipratropium: Patent Expiration and Manufacturer List. Retieved from https://www.drugpatentwatch.com/patents/ipratropium/